Literature DB >> 11976790

Heavy-chain antibodies in Camelidae; a case of evolutionary innovation.

Viet Khong Nguyen1, Chen Su, Serge Muyldermans, Wessel van der Loo.   

Abstract

The emergence in Camelidae species of functional antibodies devoid of light chains (referred to as heavy-chain antibodies or HCAbs) is an intriguing evolutionary event. Homodimeric HCAbs have also been documented in spotted ratfish ( Cos5-Abs) and nurse shark (NAR). To reveal the evolutionary history of HCAbs, we evaluated the phylogenetic and phenotypic relationships among HCAbs and conventional antibodies across taxa and confirmed the current viewpoint that different groups of HCAbs have evolved independently in the three lineages. At least, in the camelids, HCAbs are not the result of resuscitation of dormant genes. They are derived from the conventional antibodies within the Camelidae lineage, and are apparently the outcome of more recent adaptive changes occurring in the compartment of heteromeric antibodies. The shared structural properties of HCAbs across taxa are therefore explained by convergent evolution due to similar constraints related to the absence of pairing to the light chain. It appears that innovative evolutionary changes in Camelidae have led to a new level of antigen binding repertoire diversification and have allowed acquisition of novel antigen-receptor properties.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976790     DOI: 10.1007/s00251-002-0433-0

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

1.  Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells.

Authors:  Viet Khong Nguyen; Xiangang Zou; Marc Lauwereys; Lea Brys; Marianne Brüggemann; Serge Muyldermans
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor.

Authors:  V A Streltsov; J N Varghese; J A Carmichael; R A Irving; P J Hudson; S D Nuttall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

Review 3.  Distinct antibody species: structural differences creating therapeutic opportunities.

Authors:  Serge Muyldermans; Vaughn V Smider
Journal:  Curr Opin Immunol       Date:  2016-02-27       Impact factor: 7.486

4.  Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity.

Authors:  Jing Li; Changhua Zhou; Bin Dong; Hong Zhong; Siqi Chen; Qing Li; Zhong Wang
Journal:  Cancer Biol Ther       Date:  2016-09-19       Impact factor: 4.742

5.  Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.

Authors:  Kevin A Henry; Henk van Faassen; Doreen Harcus; Anne Marcil; Jennifer J Hill; Serge Muyldermans; C Roger MacKenzie
Journal:  Immunogenetics       Date:  2019-01-18       Impact factor: 2.846

6.  Natural and man-made V-gene repertoires for antibody discovery.

Authors:  William J J Finlay; Juan C Almagro
Journal:  Front Immunol       Date:  2012-11-15       Impact factor: 7.561

7.  The porcine antibody repertoire: variations on the textbook theme.

Authors:  John E Butler; Nancy Wertz
Journal:  Front Immunol       Date:  2012-06-27       Impact factor: 7.561

8.  Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.

Authors:  Haruki Hasegawa
Journal:  Int J Cell Biol       Date:  2013-03-05

9.  A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?

Authors:  Martin F Flajnik; Nick Deschacht; Serge Muyldermans
Journal:  PLoS Biol       Date:  2011-08-02       Impact factor: 8.029

10.  Evolutionary genomics of immunoglobulin-encoding Loci in vertebrates.

Authors:  Sabyasachi Das; Masayuki Hirano; Rea Tako; Chelsea McCallister; Nikolas Nikolaidis
Journal:  Curr Genomics       Date:  2012-04       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.